Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,644 | 356 | 97.5% |
| Education | $142.99 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,407 | 89 | $0 (2024) |
| ABBVIE INC. | $1,204 | 55 | $0 (2024) |
| UCB, Inc. | $1,045 | 95 | $0 (2024) |
| Janssen Biotech, Inc. | $678.68 | 43 | $0 (2024) |
| Lilly USA, LLC | $328.81 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $208.96 | 11 | $0 (2023) |
| PFIZER INC. | $202.32 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $166.70 | 9 | $0 (2023) |
| Horizon Therapeutics plc | $163.81 | 4 | $0 (2021) |
| GlaxoSmithKline, LLC. | $126.96 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $775.98 | 42 | ABBVIE INC. ($271.66) |
| 2023 | $2,004 | 120 | UCB, Inc. ($568.16) |
| 2022 | $1,597 | 109 | Amgen Inc. ($457.71) |
| 2021 | $1,410 | 87 | Amgen Inc. ($271.88) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/02/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: Immunology | ||||||
| 06/28/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Immunology | ||||||
| 05/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 05/08/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Inflammation | ||||||
| 04/17/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Immunology | ||||||
| 04/12/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Inflammation | ||||||
| 04/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $90.00 | General |
| Category: Immunology | ||||||
| 03/27/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Inflammation | ||||||
| 03/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 03/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Immunology | ||||||
| 03/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Inflammation | ||||||
| 03/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Immunology | ||||||
| 03/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Immunology | ||||||
| 02/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 459 | 4,572 | $214,891 | $99,347 |
| 2022 | 10 | 479 | 3,547 | $180,854 | $81,980 |
| 2021 | 10 | 365 | 1,978 | $98,116 | $47,361 |
| 2020 | 6 | 552 | 642 | $76,641 | $26,245 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 43 | 3,900 | $132,600 | $71,140 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 239 | $45,410 | $17,529 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 157 | $21,038 | $6,396 | 30.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $8,802 | $3,208 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 78 | 129 | $6,321 | $984.26 | 15.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 120 | $720.00 | $90.30 | 12.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 31 | 2,880 | $89,280 | $49,318 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 163 | $30,970 | $12,294 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 177 | $23,718 | $9,094 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $11,736 | $4,860 | 41.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 18 | 57 | $10,089 | $2,121 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,446 | $1,636 | 36.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 34 | 34 | $4,556 | $1,414 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 49 | 89 | $4,361 | $783.28 | 18.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $1,230 | $394.02 | 32.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 18 | 78 | $468.00 | $65.94 | 14.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 24 | 1,560 | $45,240 | $25,651 | 56.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 125 | $13,750 | $6,519 | 47.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 92 | $14,720 | $6,071 | 41.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $11,700 | $5,142 | 43.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 26 | $5,460 | $1,961 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $2,160 | $783.14 | 36.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 50 | 72 | $3,528 | $656.01 | 18.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 20 | 29 | $580.00 | $229.47 | 39.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 12 | 12 | $516.00 | $181.68 | 35.2% |
About Kevin Baker
Kevin Baker is a Registered Nurse healthcare provider based in Centerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2020. The National Provider Identifier (NPI) number assigned to this provider is 1023658218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kevin Baker has received a total of $5,787 in payments from pharmaceutical and medical device companies, with $775.98 received in 2024. These payments were reported across 358 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($5,644).
As a Medicare-enrolled provider, Baker has provided services to 1,855 Medicare beneficiaries, totaling 10,739 services with total Medicare billing of $254,933. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Centerville, OH
- Active Since 01/15/2020
- Last Updated 10/05/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1023658218
Products in Payments
- RINVOQ (Biological) $1,150
- Cimzia (Drug) $1,045
- TREMFYA (Drug) $608.23
- Enbrel (Biological) $562.48
- EVENITY (Biological) $518.73
- Otezla (Drug) $269.65
- TALTZ (Drug) $251.71
- XELJANZ (Drug) $202.32
- SAPHNELO (Biological) $166.70
- KRYSTEXXA (Biological) $163.81
- COSENTYX (Biological) $138.27
- BENLYSTA (Biological) $126.96
- COSENTYX (Drug) $70.69
- REMICADE (Biological) $70.45
- IDACIO (Biological) $54.99
- ACTHAR (Biological) $53.04
- HUMIRA (Biological) $38.81
- TAVNEOS (Drug) $29.40
- Tymlos (Biological) $20.58
- PURIFIED CORTROPHIN GEL (Drug) $19.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Centerville
Emily Dowd, Fnp, FNP
Registered Nurse — Payments: $9,450
Mr. Anthony Amagwu, Cnp, CNP
Registered Nurse — Payments: $3,544
Bonnie Loesch, Cnp, CNP
Registered Nurse — Payments: $1,824
Ms. Kimberly Leary, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $719.87
Christie Astor, Cnp, CNP
Registered Nurse — Payments: $301.68
Ms. Lauree Lawler, Cnp, CNP
Registered Nurse — Payments: $210.07